Xpressions Blog

We share our insights and information about biologic drug development, including: innovative technologies that save time and create efficiencies with a goal of getting novel drugs to patients FASTER.

Xpressions Blog

DECEMBER 4, 2019
2 min read

Cell Line Development: It’s More Complicated Than You Think

Just as it is well understood that silicon chips must be made in sophisticated factories with the appropriate...

Read More
SEPTEMBER 18, 2019
2 min read

Selexis as a Great Place to Work: Confessions from the New Kid

With 10 years of university experience, a PhD and a hunger for new challenges and experiences, I left Finland to pursue...

Read More
AUGUST 21, 2019
3 min read

Selexis Welcomes Business Development Colleagues Jessica Bosc and Samuel Rubin to Boston and San Francisco

YEMI ONAKUNLE: My work helping to lead new business development efforts at Selexis continues to challenge and inspire...

Read More
APRIL 23, 2019
4 min read

Wrapped up Q1 and Looking Back at 2018!

In early April, we were thrilled to announce that the fifth Selexis SUREtechnology-generated product was approved in...

Read More
JANUARY 30, 2019
4 min read

Lessons Learned from a Biotech CEO*

Trusting Your Talent and Team to Push the Boundaries of Technology and Innovation: Lessons Learned from a Biotech CEO

...
Read More
OCTOBER 3, 2018
3 min read

Selexis and IAVI: Advancing Possibilities in AIDS Vaccine Development

As a child growing up in Nigeria, I had first-hand experience of the suffering caused by debilitating diseases such as...

Read More
JULY 31, 2018
3 min read

Selexis SUREtechnology Platform - The Formula 1 Race Car of Cell Line Development

In building a marketing campaign for our lead technology, we wanted something that would reflect and represent the...

Read More
JULY 17, 2018
4 min read

Best-in-Class Cell Line Development and Biologic Manufacturing Coming Together

The CEOs of Selexis SA and KBI Biopharma Answer Some Common Questions (An interview from BIO 2018)

Selexis CEO Igor...

Read More
MAY 17, 2018
2 min read

Selexis: It’s a Great Place to Work®

The important thing is not to stop questioning. Curiosity has its own reason for existing. – Albert Einstein

As an...

Read More
MAY 2, 2018
1 min read

Selexis Achieves 100th Commercial License Agreement

In 2001, I co-founded Selexis with prize money that I won from the de Vigier Foundation in Switzerland followed by the...

Read More
FEBRUARY 22, 2018
3 min read

Knowledge Is Power for Today's CEOs - Keeping Up With Industry News

As a young scientist and entrepreneur, I understood early in my career just how important it is to stay ahead of the...

Read More
FEBRUARY 1, 2018
2 min read

Using CHO "Omics" to Address Production of Increasingly Complex Biotherapeutics

Increasingly, solutions for complex human diseases are being addressed with increasingly complex protein therapeutic...

Read More
JANUARY 4, 2018
3 min read

2017: Year in Review

An idea is something that won’t work unless you do. – Thomas Edison

As I look around our new corporate headquarters...

Read More
DECEMBER 21, 2017
3 min read

Biosimilarity: It starts by selecting the right manufacturing cell line

The recombinant therapeutic patent cliff has ushered in a new promise for access to less expensive biologic therapies,...

Read More
NOVEMBER 30, 2017
2 min read

CHO Cells Are Here to Stay?

I have recently read a couple of industry articles around cell line development that claim the Chinese hamster ovary...

Read More

Featured